NM_001015880.2:c.121C>T
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001015880.2(PAPSS2):c.121C>T(p.Arg41*) variant causes a stop gained change. The variant allele was found at a frequency of 0.0000448 in 1,608,550 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001015880.2 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PAPSS2 | ENST00000456849.2 | c.121C>T | p.Arg41* | stop_gained | Exon 2 of 13 | 1 | NM_001015880.2 | ENSP00000406157.1 | ||
PAPSS2 | ENST00000361175.8 | c.121C>T | p.Arg41* | stop_gained | Exon 2 of 12 | 1 | ENSP00000354436.4 | |||
PAPSS2 | ENST00000465996.5 | n.143C>T | non_coding_transcript_exon_variant | Exon 2 of 3 | 2 | |||||
PAPSS2 | ENST00000482258.1 | n.164C>T | non_coding_transcript_exon_variant | Exon 2 of 3 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000529 AC: 8AN: 151268Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000199 AC: 5AN: 251180Hom.: 0 AF XY: 0.00000737 AC XY: 1AN XY: 135742
GnomAD4 exome AF: 0.0000439 AC: 64AN: 1457282Hom.: 0 Cov.: 29 AF XY: 0.0000538 AC XY: 39AN XY: 725228
GnomAD4 genome AF: 0.0000529 AC: 8AN: 151268Hom.: 0 Cov.: 32 AF XY: 0.0000271 AC XY: 2AN XY: 73768
ClinVar
Submissions by phenotype
Spondyloepimetaphyseal dysplasia, PAPSS2 type Pathogenic:3
This variant was classified as: Pathogenic. The following ACMG criteria were applied in classifying this variant: PVS1,PM2,PP4. This variant was detected in homozygous state. -
This sequence change creates a premature translational stop signal (p.Arg41*) in the PAPSS2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PAPSS2 are known to be pathogenic (PMID: 22791835, 23633440). This variant is present in population databases (rs201203612, gnomAD 0.006%). This premature translational stop signal has been observed in individual(s) with brachyolmia (PMID: 31313512). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 932064). For these reasons, this variant has been classified as Pathogenic. -
- -
not provided Pathogenic:2
- -
- -
PAPSS2-related disorder Pathogenic:1
The PAPSS2 c.121C>T variant is predicted to result in premature protein termination (p.Arg41*). This variant was reported in the homozygous state in two members of a family affected with brachyolmia (Bownass et al 2019. PubMed ID: 31313512). This variant is reported in 0.0054% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/10-89469046-C-T). Nonsense variants in PAPSS2 are expected to be pathogenic. This variant is interpreted as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at